CNR Institutional Research Information System

NASI, SERGIO

NASI, SERGIO  

Istituto di Biologia e Patologia Molecolari - IBPM  

Mostra records
Risultati 1 - 20 di 34 (tempo di esecuzione: 0.037 secondi).
Titolo Data di pubblicazione Autore(i) File
Copper/MYC/CTR1 interplay: A dangerous relationship in hepatocellular carcinoma 1-gen-2018 Porcu C.; Antonucci L.; Barbaro B.; Illi B.; Nasi S.; Martini M.; Licata A.; Miele L.; Grieco A.; Balsano C.
c-MYC inhibition impairs hypoxia response in glioblastoma multiforme 1-gen-2016 Mongiardi, Mp; Savino, M; Falchetti, Ml; Illi, B; Bozzo, F; Valle, C; Helmercitterich, M; Ferrè, F; Nasi, S; Levi, A
Resetting cancer stem cell regulatory nodes upon MYC inhibition. 1-gen-2016 Galardi, S; Savino, M; Scagnoli, F; Pellegatta, S; Pisati, F; Zambelli, F; Illi, B; Annibali, D; Beji, S; Orecchini, E; Alberelli, Ma; Apicella, C; Fontanella, Ra; Michienzi, A; Finocchiaro, G; Farace, Mg; Pavesi, G; Ciafrè, Sa; Nasi, S
Cancer: We should not forget the past 1-gen-2015 di Lonardo A.; Nasi S.; Pulciani S.
Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells. 1-gen-2015 Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B.
MiR-21 is an Ngf-modulated MicroRNA That supports Ngf signaling and regulates neuronal degeneration in PC12 cells 1-gen-2014 Montalban, E; Mattugini, N; Ciarapica, R; Provenzano, C; Savino, M; Scagnoli, F; Prosperini, G; Carissimi, C; Fulci, V; Matrone, C; Calissano, P; Nasi, S
Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis 1-gen-2014 Annibali D; Whitfield JR; Favuzzi E; Jauset T; Serrano E; Cuartas I; RedondoCampos S; Folch G; GonzàlezJuncà A; Sodir NM; MassóVallés D; Beaulieu ME; Swigart LB; Mc Gee MM; Somma MP; Nasi S; Seoane J; Evan GI; Soucek L.
A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2 1-gen-2012 Annibali, D; Gioia, U; Savino, M; Laneve, P; Caffarelli, E; Nasi, S
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma. 1-gen-2012 Cenci T; Martini M; Montano N; D'Alessandris QG; Falchetti ML; Annibali D; Savino M; Bianchi F; Pierconti F; Nasi S; Pallini R; Larocca LM.
The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy 1-gen-2011 Savino, M; Annibali, D; Carucci, N; Favuzzi, E; Cole, Md; Evan, Gi; Soucek, L; Nasi, S
Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation. 1-gen-2009 Ciarapica R; Annibali D; Raimondi L; Savino M; Nasi S; Rota R.
Modelling Myc inhibition as a cancer therapy 1-gen-2008 Soucek L; Whitfield J; Martins C; Finch A; Murphy D; Sodir N; Karnezis A; Brown Swigart L; Nasi S.;Evan G.
Non coding RNA and brain 1-gen-2006 Presutti, C; Rosati, J; Vincenti, S; Nasi, S
From databases to modelling of functional pathways. 1-gen-2004 Nasi, Sergio
Omomyc expression in skin prevents Myc-induced papillomatosis. 1-gen-2004 Soucek L; Nasi S; Evan G.
Molecular recognition in helix-loop-helix and helix-loop-helix-l eucine zipper domains. Design of repertoires and selection of high affinity ligands for natural proteins 1-gen-2003 Ciarapica, R; Rosati, J; Cesareni, G; Nasi, S
NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interaction 1-gen-2002 Mandolesi G. ; Gargano S. ; Pennuto M. ; Illi B. ; Molfetta R. ; Soucek L. ; Mosca L. ; Levi A. ; Jucker R. ; Nasi S.
Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis. 1-gen-2002 Soucek, L; Jucker, R; Panacchia, L; Ricordy, R; Tatò, F; Nasi, S
Making decisions through Myc 1-gen-2001 Nasi S; Ciarapica R; Jucker R; Rosati J; Soucek L.
Design and properties of a Myc derivative that efficiently homodimerizes 1-gen-1998 Soucek L; HelmerCitterich M; Sacco A; Jucker R; Cesareni G; Nasi S.